Clinical Trial Update: Study of a-Interferon With Adriamycin, Bleomycin, Velban, and Dacarbazine (ABVD) With Hodgkin's Disease [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the addition of alpha-interferon to the ABVD chemotherapy regimen for Hodgkin lymphoma; the study completed and results were p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hodgkin Lymphoma

Drugs mentioned

• Adriamycin (doxorubicin)
• Bleomycin (bleomycin)
• DTIC-Dome (dacarbazine)
• Interferon-alpha (interferon alpha)
• Velban (vinblastine)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Lymphoma | Phase 2 | Status: COMPLETED | Results posted: 2013-02-01